David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$397M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$342M |
| 3 |
Bank of America
BAC
|
+$322M |
| 4 |
Citigroup
C
|
+$260M |
| 5 |
Booking.com
BKNG
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$637M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$397M |
| 3 |
Gilead Sciences
GILD
|
+$358M |
| 4 |
Phillips 66
PSX
|
+$330M |
| 5 |
Apple
AAPL
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.78% |
| 2 | Technology | 11.11% |
| 3 | Financials | 10% |
| 4 | Consumer Discretionary | 8.83% |
| 5 | Communication Services | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RDC
2476
CALL
DELISTED
Rowan Companies Plc
RDC
| $805K | ﹤0.01% |
50,000
| – | – |
|
2477
El Pollo Loco
LOCO
$478M
| $804K | ﹤0.01% |
60,265
+44,736
| +288% | +$563K |
|
|
TWO
2478
Two Harbors Investment
TWO
$1.28B
| $802K | ﹤0.01% |
12,629
-18,897
| -60% | -$1.17M |
|
2479
Viatris
VTRS
$19.2B
| $801K | ﹤0.01% |
17,298
-435,240
| -96% | -$21M |
|
|
EMC
2480
PUT
DELISTED
EMC CORPORATION
EMC
| $800K | ﹤0.01% |
30,000
-190,000
| -86% | -$4.81M |
|
2481
Acadia Pharmaceuticals
ACAD
$5.27B
| $799K | ﹤0.01% |
28,566
-36,184
| -56% | -$789K |
|
|
VNET
2482
CALL
VNET Group
VNET
$1.96B
| $799K | ﹤0.01% |
40,000
| – | – |
|
|
SGY
2483
DELISTED
Stone Energy
SGY
| $798K | ﹤0.01% |
17,784
+13,067
| +277% | +$1.69M |
|
2484
CALL
Synaptics
SYNA
$3.71B
| $797K | ﹤0.01% |
10,000
-54,200
| -84% | -$4.11M |
|
2485
PUT
Vertex Pharmaceuticals
VRTX
$140B
| $795K | ﹤0.01% |
+10,000
| New | +$905K |
|
|
QUNR
2486
CALL
DELISTED
Qunar Cayman Islands Limited
QUNR
| $794K | ﹤0.01% |
20,000
+10,000
| +100% | +$385K |
|
|
TLMR
2487
DELISTED
TALMER BANCORP INC (MI)
TLMR
| $793K | ﹤0.01% |
43,849
+5,402
| +14% | +$91.2K |
|
|
DCOM
2488
DELISTED
Dime Community Bancshares
DCOM
| $793K | ﹤0.01% |
45,025
+10,610
| +31% | +$179K |
|
2489
Virtu Financial
VIRT
$5.76B
| $788K | ﹤0.01% |
35,633
+10,085
| +39% | +$223K |
|
|
BT
2490
DELISTED
BT Group plc (ADR)
BT
| $788K | ﹤0.01% |
+24,556
| New | +$822K |
|
2491
Comtech Telecommunications
CMTL
$53M
| $787K | ﹤0.01% |
33,661
+13,532
| +67% | +$277K |
|
2492
Advanced Energy
AEIS
$11B
| $785K | ﹤0.01% |
22,551
-44,684
| -66% | -$1.31M |
|
|
ININ
2493
DELISTED
Interactive Intelligence Group, inc.
ININ
| $785K | ﹤0.01% |
+21,560
| New | +$625K |
|
2494
PUT
HCA Healthcare
HCA
$92.8B
| $781K | ﹤0.01% |
10,000
-70,000
| -88% | -$4.89M |
|
2495
CALL
Sarepta Therapeutics
SRPT
$2B
| $781K | ﹤0.01% |
40,000
+30,000
| +300% | +$524K |
|
|
IMGN
2496
DELISTED
Immunogen Inc
IMGN
| $778K | ﹤0.01% |
91,297
-534,832
| -85% | -$4.52M |
|
2497
Evolent Health
EVH
$553M
| $777K | ﹤0.01% |
73,568
+9,266
| +14% | +$95.7K |
|
2498
Cboe Global Markets
CBOE
$32.3B
| $775K | ﹤0.01% |
11,870
-400
| -3% | -$25.5K |
|
|
SCTY
2499
CALL
DELISTED
SolarCity Corporation
SCTY
| $774K | ﹤0.01% |
31,500
-125,500
| -80% | -$3.58M |
|
|
INN
2500
Summit Hotel Properties
INN
$669M
| $770K | ﹤0.01% |
+64,356
| New | +$685K |
|
Similar funds
David Shaw's Q1 2016 Portfolio in Review
As of Q1 2016, David Shaw held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
Against the trend, David Shaw opened a new position in EQT Corp worth $47.6M.
- David Shaw's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
- David Shaw added most to Allergan plc in Q1 2016, an estimated $397M increase.
- David Shaw's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
- David Shaw fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
- David Shaw's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
- David Shaw opened 382 new positions and closed 773 in Q1 2016.
- David Shaw's portfolio value fell 17% quarter-over-quarter to $55.7B.
Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.